Marion Delarue
Overview
Explore the profile of Marion Delarue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liebscher M, White S, Hass S, Chocat A, Mezenge F, Landeau B, et al.
Biol Psychiatry Glob Open Sci
. 2025 Feb;
5(2):100431.
PMID: 39990626
Background: Increased stress is a proposed risk factor for Alzheimer's disease (AD). We examined cross-sectional associations between circulating stress biomarkers and multimodal measures of brain health and cognition susceptible to...
2.
Chauveau L, Landeau B, Dautricourt S, Turpin A, Delarue M, Hebert O, et al.
Brain
. 2025 Jan;
PMID: 39813142
Curing Alzheimer's disease remains hampered by an incomplete understanding of its pathophysiology and progression. Exploring dysfunction in medial temporal lobe networks, particularly the anterior-temporal (AT) and posterior-medial (PM) systems, may...
3.
Haudry S, Turpin A, Landeau B, Mezenge F, Delarue M, Hebert O, et al.
Sci Rep
. 2024 Nov;
14(1):29521.
PMID: 39604423
Meditation is a mental training approach that can improve mental health and well-being in aging. Yet the underlying mechanisms remain unknown. The Medit-Ageing model stipulates that three mechanisms - attentional,...
4.
Requier F, Demnitz-King H, Frison E, Delarue M, Gonneaud J, Chetelat G, et al.
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn
. 2024 Jul;
32(2):252-269.
PMID: 39017643
Aging is associated with cognitive changes, even in the absence of brain pathology. This study aimed to determine if meditation training, by comparison to active and passive control groups, is...
5.
Ourry V, Rehel S, Andre C, Mary A, Paly L, Delarue M, et al.
Aging (Albany NY)
. 2023 Sep;
15(18):9275-9292.
PMID: 37770186
Sleep, especially slow wave sleep (SWS), is essential for cognitive functioning and is reduced in aging. The impact of sleep quality on cognition is variable, especially in aging. Cognitive reserve...
6.
Demnitz-King H, Requier F, Whitfield T, Schlosser M, Gonneaud J, Ware C, et al.
JAMA Netw Open
. 2023 Jul;
6(7):e2317848.
PMID: 37450303
Importance: Nonpharmacological interventions are a potential strategy to maintain or promote cognitive functioning in older adults. Objective: To investigate the effects of 18 months' meditation training and 18 months' non-native...
7.
Whitfield T, Demnitz-King H, Schlosser M, Barnhofer T, Frison E, Coll-Padros N, et al.
Alzheimers Res Ther
. 2022 Sep;
14(1):125.
PMID: 36068621
Background: Older individuals with subjective cognitive decline (SCD) perceive that their cognition has declined but do not show objective impairment on neuropsychological tests. Individuals with SCD are at elevated risk...
8.
Palix C, Felisatti F, Gonneaud J, Kuhn E, Mezenge F, Landeau B, et al.
Neurobiol Aging
. 2022 Jul;
118:25-33.
PMID: 35843110
Vascular risk factors such as hyperglycemia and platelet hyperactivation play a significant role in type 2 diabetes (T2D), a risk factor for AD. We investigated the relationships between glycemia levels,...
9.
Jansen W, Janssen O, Tijms B, Vos S, Ossenkoppele R, Visser P, et al.
JAMA Neurol
. 2022 Jan;
79(3):228-243.
PMID: 35099509
Importance: One characteristic histopathological event in Alzheimer disease (AD) is cerebral amyloid aggregation, which can be detected by biomarkers in cerebrospinal fluid (CSF) and on positron emission tomography (PET) scans....
10.
Janssen O, Jansen W, Vos S, Boada M, Parnetti L, Gabryelewicz T, et al.
Alzheimers Dement
. 2021 Dec;
18(10):1832-1845.
PMID: 34877782
Introduction: The evidence for characteristics of persons with subjective cognitive decline (SCD) associated with amyloid positivity is limited. Methods: In 1640 persons with SCD from 20 Amyloid Biomarker Study cohort,...